{"id":"W1871529692","doi":"10.1111/jvh.12464","title":"Grazoprevir plus peginterferon and ribavirin in treatment‐naive patients with hepatitis C virus genotype 1 infection: a randomized trial","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Genentech; Merck; Eisai; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Ribavirin; Internal medicine; Gastroenterology; Adverse effect; Hepatitis C virus; Clinical endpoint; Randomized controlled trial; Virology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008994383,0.000330912,0.001519438,0.0005940422,0.0000649476,0.00007946082,0.0001071425,0.000162214,0.0001319363],"category_scores_gemma":[0.0007853723,0.0002290408,0.0002450412,0.0003344985,0.0002547682,0.0005292255,0.00005943877,0.000482684,0.00003520847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001240276,"about_ca_system_score_gemma":0.0007138698,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02280235,"about_ca_topic_score_gemma":0.0124912,"domain_scores_codex":[0.9967294,0.0006114212,0.001051766,0.000288292,0.0009104387,0.0004086759],"domain_scores_gemma":[0.9978155,0.000234393,0.0005051841,0.0002501311,0.000675521,0.0005192695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.410579,0.0005209693,0.5692095,0.00003156793,0.0002544094,0.0004313635,0.000710868,0.00001226114,0.00001743529,0.00002280497,0.0003949924,0.01781487],"study_design_scores_gemma":[0.8145316,0.01923219,0.1612709,0.0003929644,0.0002971098,0.000113598,0.0000123573,0.000480131,0.0001746877,0.0001779571,0.003066537,0.0002499977],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951693,0.0007494678,0.0002018243,0.0002555788,0.0004463792,0.001867472,0.00003413956,0.00002071752,0.001255157],"genre_scores_gemma":[0.991138,0.007138478,0.0007380708,0.0001170839,0.0004162742,0.00008193903,0.00002744026,0.00004805042,0.0002946568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4079385,"threshold_uncertainty_score":0.9837049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03152031339558758,"score_gpt":0.3171351482487579,"score_spread":0.2856148348531704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}